|
|
Fresenius' New Dialysis Offering - Daily Markets |
Daily Markets
Fresenius Medical Care (NYSE:FMS), the largest provider of dialysis products and services on the planet, recently revealed that patients and doctors in Detroit, Michigan, now have access to the most sophisticated dialysis treatment.
|
|
|
European studies find few benefits of near-normalization of blood glucose in type 2 diabetes. |
|
IQWIG: In the analysis of the studies, IQWiG found no differences between the two groups for relevant aspects of treatment. Proof or indications that one of the two treatment strategies offered more advantages or disadvantages were found neither for all-cause mortality nor for fatal heart attacks, (fatal and non-fatal) strokes, end-stage renal disease (and its pre-stages), amputations, or pre-stages of blindness. Insufficient data were available for the outcomes "quality of life” and "blindness”.
|
|
Brave new world. Hacking into the genetic code of E. Coli. |
|
New Scientist: The technique could make drug-producing bacteria immune to viruses, prevent laboratory engineered organisms from genetically contaminating wildlife and enable scientists to construct proteins that do not exist in nature.
|
|
CDC infection prevention guidelines for outpatient settings released. |
|
CDC: The following document is a summary guide of infection prevention recommendations for outpatient (ambulatory care) settings. The recommendations included in this document are not new but rather reflect existing evidence-based guidelines produced by the Centers for Disease Control and Prevention and the Healthcare Infection Control Practices Advisory Committee. This summary guide is based primarily upon elements of Standard Precautions and represents the minimum infection prevention expectations for safe care in ambulatory care settings. Readers are urged to consult the full guidelines for additional background, rationale, and evidence behind each recommendation. All guidelines are available at: Guidelines and Recommendations
|
|
NxStage® to Report Second Quarter Fiscal 2011 Financial Results - SunHerald.com |
SunHerald.com
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure
|
|
|
|
|
<< Start < Prev 791 792 793 794 795 796 797 798 799 800 Next > End >>
|
|
Page 800 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
